BRPI0810425A2 - Método para determinação do risco de progressão de glaucoma - Google Patents

Método para determinação do risco de progressão de glaucoma

Info

Publication number
BRPI0810425A2
BRPI0810425A2 BRPI0810425-5A2A BRPI0810425A BRPI0810425A2 BR PI0810425 A2 BRPI0810425 A2 BR PI0810425A2 BR PI0810425 A BRPI0810425 A BR PI0810425A BR PI0810425 A2 BRPI0810425 A2 BR PI0810425A2
Authority
BR
Brazil
Prior art keywords
progression risk
glaucoma progression
determining
determining glaucoma
risk
Prior art date
Application number
BRPI0810425-5A2A
Other languages
English (en)
Inventor
Shigeru Kinoshita
Kei Tashiro
Masakazu Nakano
Tomohito Yagi
Kazuhiko Mori
Yoko Ikeda
Takazumi Taniguchi
Masaaki Kageyama
Original Assignee
Santen Pharmaceutical Co Ltd
Shigeru Kinoshita
Kei Tashiro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd, Shigeru Kinoshita, Kei Tashiro filed Critical Santen Pharmaceutical Co Ltd
Publication of BRPI0810425A2 publication Critical patent/BRPI0810425A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI0810425-5A2A 2007-04-17 2008-04-17 Método para determinação do risco de progressão de glaucoma BRPI0810425A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007108688 2007-04-17
PCT/JP2008/057533 WO2008130009A1 (ja) 2007-04-17 2008-04-17 緑内障進行リスクの判定方法

Publications (1)

Publication Number Publication Date
BRPI0810425A2 true BRPI0810425A2 (pt) 2014-10-07

Family

ID=39875536

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0810425-5A2A BRPI0810425A2 (pt) 2007-04-17 2008-04-17 Método para determinação do risco de progressão de glaucoma
BRPI0810071-3A2A BRPI0810071A2 (pt) 2007-04-17 2008-04-17 Método para determinação do risco inicial de glaucoma

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0810071-3A2A BRPI0810071A2 (pt) 2007-04-17 2008-04-17 Método para determinação do risco inicial de glaucoma

Country Status (12)

Country Link
US (4) US8431345B2 (pt)
EP (4) EP2565270A1 (pt)
JP (5) JP5624763B2 (pt)
KR (2) KR20100016568A (pt)
CN (2) CN101679971A (pt)
AU (2) AU2008241867A1 (pt)
BR (2) BRPI0810425A2 (pt)
CA (2) CA2683691A1 (pt)
MX (2) MX2009011079A (pt)
RU (2) RU2009142225A (pt)
SG (2) SG177960A1 (pt)
WO (2) WO2008130009A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG158776A1 (en) * 2008-07-25 2010-02-26 Univ Kaohsiung Medical Using genetic polymorphisms of the bicd1 gene as a method for diagnosing and treating myopia
JP4515524B2 (ja) * 2008-11-27 2010-08-04 株式会社メニコン 正常眼圧緑内障疾患感受性遺伝子及びその利用
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US20120122703A1 (en) * 2009-07-03 2012-05-17 University College Cardiff Consultants Limited Diagnosis and treatment of alzheimer's disease
US9107617B2 (en) 2009-11-16 2015-08-18 Agency For Science, Technology And Research Obtaining data for automatic glaucoma screening, and screening and diagnostic techniques and systems using the data
WO2011152098A1 (ja) * 2010-06-04 2011-12-08 コニカミノルタエムジー株式会社 イムノクロマトグラフ法のための展開液およびそれを用いた測定法
US9708664B2 (en) 2012-04-20 2017-07-18 University Of Virginia Patent Foundation Compositions and methods for identifying and diagnosing salt sensitivity of blood pressure
EP2888718B1 (en) 2012-08-24 2018-01-17 Agency For Science, Technology And Research Methods and systems for automatic location of optic structures in an image of an eye, and for automatic retina cup-to-disc ratio computation
US10648035B2 (en) 2012-11-26 2020-05-12 The Johns Hopkins University Methods and compositions for diagnosing and treating gastric cancer
RU2508043C1 (ru) * 2012-12-20 2014-02-27 федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ прогнозирования развития открытоугольной глаукомы у пациентов с глазными проявлениями псевдоэксфолиативного синдрома
US20150315645A1 (en) * 2014-05-03 2015-11-05 The Regents Of The University Of California Methods of identifying biomarkers associated with or causative of the progression of disease
RU2580306C1 (ru) * 2015-03-26 2016-04-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития первичной открытоугольной глаукомы у индивидуумов в зависимости от наличия/отсутствия сопутствующих неинфекционных заболеваний глаз
RU2585381C1 (ru) * 2015-03-27 2016-05-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования показателей гидродинамики у больных первичной открытоугольной глаукомой
JP6542037B2 (ja) * 2015-06-04 2019-07-10 シスメックス株式会社 関節リウマチ患者におけるメトトレキサートの有効性の診断を補助する方法
JP7072803B2 (ja) * 2016-06-30 2022-05-23 京都府公立大学法人 広義原発開放隅角緑内障の発症リスクの判定方法
JP7064215B2 (ja) * 2016-08-05 2022-05-10 京都府公立大学法人 落屑症候群又は落屑緑内障の発症リスクの判定方法
WO2020002602A1 (fr) 2018-06-29 2020-01-02 bioMérieux Procédé pour déterminer in vitro ou ex vivo le statut immunitaire d'un individu
EP4042426A1 (en) * 2019-10-31 2022-08-17 Google LLC Using machine learning-based trait predictions for genetic association discovery
CN113444788B (zh) * 2021-08-27 2021-11-02 中国医学科学院北京协和医院 青光眼诊断产品及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5686407A (en) * 1995-08-16 1997-11-11 Alcon Laboratories, Inc. Hepatocyte growth factor to treat glaucoma
US5962230A (en) * 1997-02-13 1999-10-05 The University Of Connecticut Diagnosis and treatment of glaucoma
JP2000306165A (ja) 1999-02-19 2000-11-02 Toshiba Tec Corp 医療費控除用レシート発行装置および記録媒体
JP2002306165A (ja) 2000-05-17 2002-10-22 Tsubota:Kk 正常眼圧緑内障を含む開放隅角緑内障の関連遺伝子
WO2005090602A2 (en) 2004-03-18 2005-09-29 Sucampo Ag Method for diagnosing or predicting susceptibility to optic nueropathy
EP1647600A3 (en) * 2004-09-17 2006-06-28 Affymetrix, Inc. (A US Entity) Methods for identifying biological samples by addition of nucleic acid bar-code tags
NZ576591A (en) 2006-10-27 2012-04-27 Decode Genetics Efh Cancer susceptibility variants on chr8q24.21
US20100240057A1 (en) * 2007-11-08 2010-09-23 St. Jude Children's Research Hospital Methods and compositions for the diagnosis and treatment of chronic myeloid leukemia and acute lymphoblastic leukemia

Also Published As

Publication number Publication date
US20130210668A1 (en) 2013-08-15
CA2683691A1 (en) 2008-10-30
US20130012408A1 (en) 2013-01-10
JPWO2008130009A1 (ja) 2010-07-22
EP2147975A4 (en) 2010-11-10
SG177960A1 (en) 2012-02-28
JP2013150628A (ja) 2013-08-08
JPWO2008130008A1 (ja) 2010-07-22
AU2008241867A1 (en) 2008-10-30
JP6203217B2 (ja) 2017-09-27
WO2008130009A1 (ja) 2008-10-30
US8431345B2 (en) 2013-04-30
EP2161334A4 (en) 2010-11-10
JP2017201995A (ja) 2017-11-16
CN101679970A (zh) 2010-03-24
MX2009011080A (es) 2010-03-10
CN101679971A (zh) 2010-03-24
RU2009142225A (ru) 2011-05-27
US20110207122A1 (en) 2011-08-25
BRPI0810071A2 (pt) 2014-10-14
JP5624763B2 (ja) 2014-11-12
WO2008130008A1 (ja) 2008-10-30
RU2009142223A (ru) 2011-05-27
EP2548961A1 (en) 2013-01-23
EP2147975A1 (en) 2010-01-27
KR20100016568A (ko) 2010-02-12
US20100196895A1 (en) 2010-08-05
EP2565270A1 (en) 2013-03-06
JP2015180219A (ja) 2015-10-15
KR20100016525A (ko) 2010-02-12
AU2008241868A1 (en) 2008-10-30
SG177968A1 (en) 2012-02-28
CA2683836A1 (en) 2008-10-30
JP5759500B2 (ja) 2015-08-05
EP2161334A1 (en) 2010-03-10
MX2009011079A (es) 2010-03-10

Similar Documents

Publication Publication Date Title
BRPI0810425A2 (pt) Método para determinação do risco de progressão de glaucoma
BRPI0821158A2 (pt) Método para fazer lentes de contato
BRPI0812446A2 (pt) Métodos para aperfeiçoamento de propriedades de proteína múltiplas
BRPI0814359A2 (pt) Método
BRPI0817226A2 (pt) Método
BRPI0817726A2 (pt) Método
BRPI0810767A2 (pt) Método para otimizar enlaces de campo próximo
BRPI0812164A2 (pt) Técnicas para provisão automática de software
BRPI0817394A2 (pt) Método para processamento de pozzolans
BRPI0815550A2 (pt) Método para estabilizar fenilefrina
FI20075505A0 (fi) Menetelmä silmälasien valmistamiseksi
BRPI0922490A2 (pt) Método para produção de beta-santaleno
BRPI0822849A2 (pt) Aparelho para cirurgia oftalmológica
BRPI0916879A2 (pt) método de adaptação para lentes multifocais
BRPI0812741A2 (pt) Método para separação de glóbulos
BRPI0812040A2 (pt) Indicações para terapia de anti-il-i-beta
BRPI0810416A2 (pt) Método de hidroformação
BRPI0819448A2 (pt) Método para transações seguras
BRPI0814011A2 (pt) método para preparação de biobutanol
BRPI0818674A2 (pt) Método para produção de anticorpos
BRPI0912001A2 (pt) técnica para regular tráfego de enlace
BRPI0817098A2 (pt) Meios visuais para o aumento de qualidade de confeitos
ES1065457Y (es) Dispositivo de amortiguacion para quads
BR112012004454A2 (pt) " método para determinação de números de etapas de engrenagem "
ES1064720Y (es) Guia para persiana

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.